Synthomer plc (LON:SYNT - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 252.54 ($3.28) and traded as low as GBX 174.40 ($2.26). Synthomer shares last traded at GBX 175.40 ($2.28), with a volume of 314,435 shares trading hands.
Analysts Set New Price Targets
Several research analysts have issued reports on SYNT shares. Berenberg Bank cut their price target on Synthomer from GBX 375 ($4.87) to GBX 340 ($4.41) and set a "buy" rating on the stock in a report on Tuesday, August 13th. Jefferies Financial Group lifted their price target on shares of Synthomer from GBX 220 ($2.86) to GBX 250 ($3.25) and gave the company a "hold" rating in a research report on Friday, July 12th. Finally, Canaccord Genuity Group lowered their price objective on shares of Synthomer from GBX 300 ($3.90) to GBX 275 ($3.57) and set a "buy" rating on the stock in a report on Friday, October 4th.
View Our Latest Stock Analysis on SYNT
Synthomer Stock Up 2.2 %
The company has a market capitalization of £293.12 million, a P/E ratio of -294.43, a PEG ratio of -0.17 and a beta of 1.79. The stock has a 50 day moving average price of GBX 215.54 and a 200 day moving average price of GBX 252.54. The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Further Reading
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.